FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Katharine Herrick-Davis

Research Profile

Chemicals & Drugs

Procedures

Radioligand Assay

Living Beings

Rats
Mouse

Physiology

Anatomy

Concepts & Ideas

Co-author Network

Publications

TOP 3
Katharine Herrick-Davis; Tara Lindsley; Ann Cowan; Ellinor Grinde; Joseph E Mazurkiewicz
Oligomer size of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor revealed by fluorescence correlation spectroscopy with photon counting histogram analysis: evidence for homodimers without monomers or tetramers.
Katharine Herrick-Davis; Ellinor Grinde; Barbara A Weaver
Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment.
Carol Smith; Tariq Rahman; Nicole Toohey; Joseph E Mazurkiewicz; Katharine Herrick-Davis; Milt Teitler
Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Katharine Herrick-Davis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Katharine Herrick-Davis; Tara Lindsley; Ann Cowan; Ellinor Grinde; Joseph E Mazurkiewicz
Oligomer size of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor revealed by fluorescence correlation spectroscopy with photon counting histogram analysis: evidence for homodimers without monomers or tetramers.
The Journal of biological chemistry 2012;287(28):23604-14.
2007: Katharine Herrick-Davis; Ellinor Grinde; Barbara A Weaver
Serotonin 5-HT(2C) receptor homodimerization is not regulated by agonist or inverse agonist treatment.
European journal of pharmacology 2007;568(1-3):45-53.
2006: Carol Smith; Tariq Rahman; Nicole Toohey; Joseph E Mazurkiewicz; Katharine Herrick-Davis; Milt Teitler
Risperidone irreversibly binds to and inactivates the h5-HT7 serotonin receptor.
Molecular pharmacology 2006;70(4):1264-70.
2006: Katharine Herrick-Davis; Barbara A Weaver; Ellinor Grinde; Joseph E Mazurkiewicz
Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer.
The Journal of biological chemistry 2006;281(37):27109-16.
2005: Katharine Herrick-Davis; Ellinor Grinde; Timothy J Harrigan; Joseph E Mazurkiewicz
Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein.
The Journal of biological chemistry 2005;280(48):40144-51.
2005: Anil Purohit; Carol Smith; Katharine Herrick-Davis; Milt Teitler
Stable expression of constitutively activated mutant h5HT6 and h5HT7 serotonin receptors: inverse agonist activity of antipsychotic drugs.
Psychopharmacology 2005;179(2):461-9.
2005: Olga D Taraschenko; William G Barnes; Katharine Herrick-Davis; Y Yokoyama; DL Boyd; Lindsay B Hough
Actions of tacrine and galanthamine on histamine-N-methyltransferase.
Methods and findings in experimental and clinical pharmacology 2005;27(3):161-5.
2005: H M Fentress; Ellinor Grinde; Joseph E Mazurkiewicz; Jon R Backstrom; Katharine Herrick-Davis; Elaine Sanders-Bush
Pharmacological properties of the Cys23Ser single nucleotide polymorphism in human 5-HT2C receptor isoforms.
The pharmacogenomics journal 2005;5(4):244-54.
2004: Katharine Herrick-Davis; Ellinor Grinde; Joseph E Mazurkiewicz
Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells.
Biochemistry 2004;43(44):13963-71.
2004: Malgorzata Dukat; Carol Smith; Katharine Herrick-Davis; Milt Teitler; Richard A Glennon
Binding of tryptamine analogs at h5-HT1E receptors: a structure-affinity investigation.
Bioorganic & medicinal chemistry 2004;12(10):2545-52.
2004: William G Barnes; Ellinor Grinde; Dana R Crawford; Katharine Herrick-Davis; Lindsay B Hough
Characterization of a new mRNA species from the human histamine N-methyltransferase gene.
Genomics 2004;83(1):168-71.
2003: Brian Grella; Milt Teitler; Carol Smith; Katharine Herrick-Davis; Richard A Glennon
Binding of beta-carbolines at 5-HT(2) serotonin receptors.
Bioorganic & medicinal chemistry letters 2003;13(24):4421-5.
2003: Richard A Glennon; Maha Khalifa Daoud; Malgorzata Dukat; Milt Teitler; Katharine Herrick-Davis; Atul Purohit; Hasan Syed
Arylguanidine and arylbiguanide binding at 5-HT3 serotonin receptors: a QSAR study.
Bioorganic & medicinal chemistry 2003;11(20):4449-54.
2003: Nantaka Khorana; Carol Smith; Katharine Herrick-Davis; Atul Purohit; Milt Teitler; Brian Grella; Malgorzata Dukat; Richard A Glennon
Binding of tetrahydrocarboline derivatives at human 5-HT5A receptors.
Journal of medicinal chemistry 2003;46(18):3930-7.
2003: Ashraf A Rahman; Maha Khalifa Daoud; Malgorzata Dukat; Katharine Herrick-Davis; Atul Purohit; Milt Teitler; Antonia Taveres do Amaral; Alberto Malvezzi; Richard A Glennon
Conformationally-restricted analogues and partition coefficients of the 5-HT3 serotonin receptor ligands meta-chlorophenylbiguanide (mCPBG) and meta-chlorophenylguanidine (mCPG).
Bioorganic & medicinal chemistry letters 2003;13(6):1119-23.
2003: Nantaka Khorana; Atul Purohit; Katharine Herrick-Davis; Milt Teitler; Richard A Glennon
gamma-Carbolines: binding at 5-HT5A serotonin receptors.
Bioorganic & medicinal chemistry 2003;11(5):717-22.
2003: Anil Purohit; Katharine Herrick-Davis; Milt Teitler
Creation, expression, and characterization of a constitutively active mutant of the human serotonin 5-HT6 receptor.
Synapse (New York, N.Y.) 2003;47(3):218-24.
2002: Milt Teitler; Katharine Herrick-Davis; Anil Purohit
Constitutive activity of G-protein coupled receptors: emphasis on serotonin receptors.
Current topics in medicinal chemistry 2002;2(6):529-38.
2002: Jean Chang-Fong; James Addo; Malgorzata Dukat; Carol Smith; Nicholas A Mitchell; Katharine Herrick-Davis; Milt Teitler; Richard A Glennon
Evaluation of isotryptamine derivatives at 5-HT(2) serotonin receptors.
Bioorganic & medicinal chemistry letters 2002;12(2):155-8.
2001: Jagadeesh B Rangisetty; Malgorzata Dukat; C S Dowd; Katharine Herrick-Davis; A DuPre; S Gadepalli; Milt Teitler; C R Kelley; Najam A Sharif; Richard A Glennon
1-[2-methoxy-5-(3-phenylpropyl)]-2-aminopropane unexpectedly shows 5-HT(2A) serotonin receptor affinity and antagonist character.
Journal of medicinal chemistry 2001;44(20):3283-91.
2001: Malgorzata Dukat; Y N Choi; Milt Teitler; A Du Pre; Katharine Herrick-Davis; Carol Smith; Richard A Glennon
The binding of arylguanidines at 5-HT(3) serotonin receptors: a structure-affinity investigation.
Bioorganic & medicinal chemistry letters 2001;11(12):1599-603.
2001: Colleen M Niswender; Katharine Herrick-Davis; GE Dilley; Herbert Y Meltzer; James C Overholser; Craig A Stockmeier; Ronald B Emeson; Elaine Sanders-Bush
RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2001;24(5):478-91.
2000: Katharine Herrick-Davis; Ellinor Grinde; Milt Teitler
Inverse agonist activity of atypical antipsychotic drugs at human 5-hydroxytryptamine2C receptors.
The Journal of pharmacology and experimental therapeutics 2000;295(1):226-32.
2000: KK Szumlinski; Katharine Herrick-Davis; Milt Teitler; Isabelle M Maisonneuve; Stanley D D Glick
Behavioural sensitization to cocaine is dissociated from changes in striatal NMDA receptor levels.
Neuroreport 2000;11(12):2785-8.
2000: C S Dowd; Katharine Herrick-Davis; C Egan; A DuPre; Carol Smith; Milt Teitler; Richard A Glennon
1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists.
Journal of medicinal chemistry 2000;43(16):3074-84.
2000: C Egan; Ellinor Grinde; A DuPre; Bryan L Roth; M Hake; Milt Teitler; Katharine Herrick-Davis
Agonist high and low affinity state ratios predict drug intrinsic activity and a revised ternary complex mechanism at serotonin 5-HT(2A) and 5-HT(2C) receptors.
Synapse (New York, N.Y.) 2000;35(2):144-50.
1999: Katharine Herrick-Davis; Ellinor Grinde; Colleen M Niswender
Serotonin 5-HT2C receptor RNA editing alters receptor basal activity: implications for serotonergic signal transduction.
Journal of neurochemistry 1999;73(4):1711-7.
1999: Colleen M Niswender; S C Copeland; Katharine Herrick-Davis; Ronald B Emeson; Elaine Sanders-Bush
RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity.
The Journal of biological chemistry 1999;274(14):9472-8.
1998: Katharine Herrick-Davis; Ellinor Grinde; C Gauthier; Milt Teitler
Pharmacological characterization of the constitutively activated state of the serotonin 5-HT2C receptor.
Annals of the New York Academy of Sciences 1998;861():140-5.
1998: C Egan; Katharine Herrick-Davis; Milt Teitler
Creation of a constitutively activated state of the 5-HT2A receptor by site-directed mutagenesis: revelation of inverse agonist activity of antagonists.
Annals of the New York Academy of Sciences 1998;861():136-9.
1998: K A Metwally; Malgorzata Dukat; CT Egan; Carol Smith; A DuPre; C B Gauthier; Katharine Herrick-Davis; Milt Teitler; Richard A Glennon
Spiperone: influence of spiro ring substituents on 5-HT2A serotonin receptor binding.
Journal of medicinal chemistry 1998;41(25):5084-93.
1998: CT Egan; Katharine Herrick-Davis; Milt Teitler
Creation of a constitutively activated state of the 5-hydroxytryptamine2A receptor by site-directed mutagenesis: inverse agonist activity of antipsychotic drugs.
The Journal of pharmacology and experimental therapeutics 1998;286(1):85-90.
1998: Brian Grella; Malgorzata Dukat; Richard Young; Milt Teitler; Katharine Herrick-Davis; C B Gauthier; Richard A Glennon
Investigation of hallucinogenic and related beta-carbolines.
Drug and alcohol dependence 1998;50(2):99-107.
1998: CT Egan; Katharine Herrick-Davis; K Miller; Richard A Glennon; Milt Teitler
Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors.
Psychopharmacology 1998;136(4):409-14.
1997: Katharine Herrick-Davis; C Egan; Milt Teitler
Activating mutations of the serotonin 5-HT2C receptor.
Journal of neurochemistry 1997;69(3):1138-44.
1996: Richard A Glennon; S S Hong; M Bondarev; Ho Law; Malgorzata Dukat; S Rakhi; P Power; E Fan; D Kinneau; Rajender K Kamboj; Milt Teitler; Katharine Herrick-Davis; C Smith
Binding of O-alkyl derivatives of serotonin at human 5-HT1D beta receptors.
Journal of medicinal chemistry 1996;39(1):314-22.
1995: S M Pearl; Katharine Herrick-Davis; Milt Teitler; Stanley D D Glick
Radioligand-binding study of noribogaine, a likely metabolite of ibogaine.
Brain research 1995;675(1-2):342-4.
1994: Richard A Glennon; Malgorzata Dukat; M el-Bermawy; Ho Law; J De los Angeles; Milt Teitler; A King; Katharine Herrick-Davis
Influence of amine substituents on 5-HT2A versus 5-HT2C binding of phenylalkyl- and indolylalkylamines.
Journal of medicinal chemistry 1994;37(13):1929-35.
1994: Milt Teitler; Katharine Herrick-Davis
Multiple serotonin receptor subtypes: molecular cloning and functional expression.
Critical reviews in neurobiology 1994;8(3):175-88.
1989: S Leonhardt; Katharine Herrick-Davis; M Titeler
Detection of a novel serotonin receptor subtype (5-HT1E) in human brain: interaction with a GTP-binding protein.
Journal of neurochemistry 1989;53(2):465-71.
1989: Katharine Herrick-Davis; Isabelle M Maisonneuve; M Titeler
Postsynaptic localization and up-regulation of serotonin 5-HT1D receptors in rat brain.
Brain research 1989;483(1):155-7.
1989: Katharine Herrick-Davis; M Titeler
Detection and characterization of a 5HT1D serotonin receptor-GTP binding protein interaction in porcine and bovine brain.
Synapse (New York, N.Y.) 1989;3(4):325-30.
1988: Katharine Herrick-Davis; M Titeler; S Leonhardt; R Struble; D Price
Serotonin 5-HT1D receptors in human prefrontal cortex and caudate: interaction with a GTP binding protein.
Journal of neurochemistry 1988;51(6):1906-12.
1988: Katharine Herrick-Davis; M Titeler
Detection and characterization of the serotonin 5-HT 1D receptor in rat and human brain.
Journal of neurochemistry 1988;50(5):1624-31.
1988: Katharine Herrick-Davis; M Titeler
[3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties.
Journal of neurochemistry 1988;50(2):528-33.
1988: Richard A Glennon; M R Seggel; William H Soine; Katharine Herrick-Davis; R A Lyon; M Titeler
[125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors.
Journal of medicinal chemistry 1988;31(1):5-7.